At Hers, we refuse to let women be left behind.
The national shortage of estrogen patches is a stark reminder that the healthcare system still treats women’s health as an afterthought. After years of misinformation that hormone therapy increased risk of breast cancer, the FDA’s removal of the Black Box warning was a clear victory for science over stigma. But it also exposed a system in crisis. With 1.3 million women entering menopause annually, the outdated supply chain can’t keep pace with a new generation of women ready to reclaim their health and vitality.
Hers is stepping into this gap to ensure that in this moment of uncertainty, women experiencing perimenopause and menopause have a reliable health partner. For any woman seeking estrogen patches during this crisis, Hers is here to help. We have built a dependable supply, allowing us to consistently deliver access to the uninterrupted, high-quality care women deserve, with intention, compassion, and reliability at every step. We are here to ensure that women’s health, and their identity, never have to wait on a backorder.
Trust in healthcare is fragile. It’s earned through action, not promises. While industry experts warn that shortages could persist for years, we refuse to accept that as the status quo for our customers. Managing menopause symptoms isn't a nice-to-have. Hot flashes, night sweats, and disrupted sleep can sideline women from their own lives. At Hers, we’ve replaced traditional hurdles with individualized care, offering eligible customers personalized treatment plans featuring estradiol and progesterone tailored to their specific health history and personal preferences.
Women can refine their treatment plans anytime in partnership with licensed providers and a Care Team trained in perimenopause and menopause care. Beyond the medication, Hers provides a holistic ecosystem of expert-led content in our app, spanning wellness, nutrition, and sleep. The entire experience is designed to ensure women don’t just manage this transition, but thrive through it.
Women shouldn't have to put their lives on hold while the rest of the industry plays catch-up. At Hers, we are all-in on supporting women at every stage of life, ensuring that the care they need is available exactly when they need it.
Cautionary Note Regarding Forward-Looking Statements
This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “anticipates,” “expects,” “intends,” “plans,” “decides,” “may,” “will,” “likely,” “potential,” “future,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding supply of estrogen patches and access to perimenopause and menopause care. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, customer and market demand; supply chain constraints or interruptions; changes or interpretations in healthcare, consumer protection or privacy laws or regulations; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this communication are made only as of April 16, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
.jpg)
